$18.17
-0.95-4.97%
al cierre: Nov 17, 4:00 PM EST
$18.17
-0.95-4.97%
Premercado: 4:09 AM EST
The average analyst price target for Seaport Therapeutics is $37.13, 104.3% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $28 to $50. The latest change came on Nov 5, 2026, when JP Morgan raised its price target on Seaport Therapeutics from $40 to $41 and kept an Overweight rating.
Price Target Range — 3 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
